One‐year clinical outcome with a novel self‐expanding transcatheter heart valve

OBJECTIVES: To evaluate 1‐year outcome using the ACURATE neo (Symetis S.A., a Boston Scientific Company, Ecublens, Switzerland) according to the updated Valve Academic Research Consortium (VARC‐2) with emphasis on the composite endpoints “clinical efficacy after 30 days” and “time‐related valve safe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Catheter Cardiovasc Interv
Huvudupphovsmän: Pellegrini, Costanza, Rheude, Tobias, Trenkwalder, Teresa, Mayr, N. Patrick, Michel, Jonathan, Kastrati, Adnan, Schunkert, Heribert, Kasel, Albert M., Joner, Michael, Hengstenberg, Christian, Husser, Oliver
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2019
Ämnen:
VALVULAR AND STRUCTURAL HEART DISEASES
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899934/
https://ncbi.nlm.nih.gov/pubmed/30801906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.28144
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk